Raphaël Ceccaldi

6.4k citations
22 papers · 4.5k · 5 hit papers · h-index 18

Impact in

  • Oncology top 1%
    • PARP inhibition in cancer therapy
    • Cancer-related Molecular Pathways
    • DNA Repair Mechanisms
    • CRISPR and Genetic Engineering
    • Genomics and Chromatin Dynamics

Papers in

    • DNA Repair Mechanisms 17
    • CRISPR and Genetic Engineering 5
    • Genomics and Chromatin Dynamics 3
    • PARP inhibition in cancer therapy 8
    • Cancer-related Molecular Pathways 3

Raphaël Ceccaldi

22 papers receiving 4.4k citations

Raphaël Ceccaldi's Hit Papers

A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors 2021 · 232 citations
2320+3+7Years since publication2505007501000

Peers

Raphaël Ceccaldi
Comparison fields: 5 of 100
  • Oncology 1.8k
  • Molecular Biology 3.4k
  • Reproductive Medicine 307
  • Cancer Research 531
  • Aging 55
Replace Madalena Tarsounas with:
Madalena Tarsounas United Kingdom
Andrew J. Pierce United States
Manuel Stucki Switzerland
Jekaterina Ērenpreisa Latvia
Sally Swift United Kingdom
Hannah Farmer United Kingdom
Andrew N. Blackford United Kingdom
Rachel Brough United Kingdom
Rémi Buisson United States
E. Marielle Hijmans Netherlands
Raphaël Ceccaldi relative to Madalena Tarsounas United Kingdom Madalena Tarsounas's profile →
Citations per field
00.5×1.5×1.8×
Madalena Tarsounas · 1×
Citations per year

Countries citing papers authored by Raphaël Ceccaldi

Since Specialization
Citations

This map shows the geographic impact of Raphaël Ceccaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphaël Ceccaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphaël Ceccaldi more than expected).

Fields of papers citing papers by Raphaël Ceccaldi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphaël Ceccaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphaël Ceccaldi. The network helps show where Raphaël Ceccaldi may publish in the future.

Co-authors

The 25 scholars most cited alongside Raphaël Ceccaldi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Raphaël Ceccaldi Line = papers co-authored together Raphaël Ceccaldi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Repair Pathway Choices and Consequences at the Double-Strand Break
Hit paper breakdown →
20151136
2
Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair
Hit paper breakdown →
2015677
3
Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer
Hit paper breakdown →
2015641
4
The Fanconi anaemia pathway: new players and new functions
Hit paper breakdown →
2016516
5 2017263
6 2012244
7
A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors
Hit paper breakdown →
2021232
8 2016150
9 2016109
10 2015101
11 2018101
12 202369
13 201051
14 202349
15 201446
16 201327
17 201222
18 202517
19 20256
20 20233

About Raphaël Ceccaldi

Raphaël Ceccaldi is a scholar working on Molecular Biology, Oncology, Cancer Research, Cell Biology and Plant Science, having authored 22 papers that have together received 4.5k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (17 papers), PARP inhibition in cancer therapy (8 papers), CRISPR and Genetic Engineering (5 papers), Carcinogens and Genotoxicity Assessment (4 papers), Microtubule and mitosis dynamics (3 papers), Cancer-related Molecular Pathways (3 papers), Genomics and Chromatin Dynamics (3 papers) and Plant Genetic and Mutation Studies (2 papers). The work is most often cited by research in Oncology (1.8k citations), Molecular Biology (3.4k citations), Reproductive Medicine (307 citations), Cancer Research (531 citations) and Aging (55 citations). Raphaël Ceccaldi has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Alan D. D’Andrea, Beatrice Rondinelli, Panagiotis A. Konstantinopoulos, Geoffrey I. Shapiro, Prabha Sarangi, Kevin W. O’Connor, Mark I.R. Petalcorin, Timur Yusufzai, Ravindra Amunugama and Ildikó Hajdú. Their work appears in journals such as Molecular Cell, Nature Reviews Molecular Cell Biology, Journal of Clinical Investigation, Nature and Cell stem cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact